Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
29 Sep 2025
See more Lidl launches €140M logistics platform in Barcelona, its biggest in SpainLidl launches €140M logistics platform in Barcelona, its biggest in Spain
-
22 Sep 2025
See more American company Digital Realty invests €230 million in a new Data Center in BarcelonaAmerican company Digital Realty invests €230 million in a new Data Center in Barcelona
-
22 Sep 2025
See more HIPRA opens new €500M Biotech campus in Catalonia, strengthening Europe’s Life Sciences hubHIPRA opens new €500M Biotech campus in Catalonia, strengthening Europe’s Life Sciences hub
-
19 Sep 2025
See more APM Terminals invests €156 million in Barcelona to boost Mediterranean logistics hubAPM Terminals invests €156 million in Barcelona to boost Mediterranean logistics hub
